Corriente Advisors’s Global Blood Therapeutics GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
Corriente Advisors's GBT Position: Q1 2020 in Review
Corriente Advisors sold out of Global Blood Therapeutics (GBT) in Q1 2020, closing a stake of 40,000 shares — an estimated $3.18M sold.
Corriente Advisors first reported a position in GBT in Q4 2019 and held it in 1 quarter. The position peaked at $3.18M in Q4 2019. 220 funds tracked by Wall St. Rank hold GBT as of Q1 2020.
- Corriente Advisors reported no remaining Global Blood Therapeutics position as of Q1 2020 after selling out during the quarter.
- Corriente Advisors sold 40,000 Global Blood Therapeutics shares in Q1 2020, an estimated $3.18M.
- Corriente Advisors first reported a position in Global Blood Therapeutics in Q4 2019 and held it in 1 quarter.
- Corriente Advisors's Global Blood Therapeutics position peaked at $3.18M in Q4 2019.
- 220 funds tracked by Wall St. Rank held Global Blood Therapeutics as of Q1 2020.
Based on Corriente Advisors's 13F filing for Q1 2020, filed 18 May 2020.